Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
NWGL - Nature Wood Group Ltd ADR - Stock Price Chart
TickerNWGL [NASD]
CompanyNature Wood Group Ltd ADR
CountryChina
IndustryLumber & Wood Production
Market Cap567.97MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.00%
Insider Trans-Inst Trans-
Short Float0.04%EarningsFeb 14/b
Analyst Recom-Target Price-
Avg Volume32.85K52W Range7.00 - 21.97
Mar-04-24 09:30AM Nature Wood Group Limited Announces Strong 2024 Guidance Driven by EU Regulations (PR Newswire) +11.83%
Feb-14-24 09:00AM Nature Wood Group Limited Announces Preliminary Full Year 2023 Financial Results (PR Newswire)
Dec-18-23 04:30PM Nature Wood Group Limited Announces First Half 2023 Unaudited Financial Results (PR Newswire) +14.60%
Nov-28-23 09:00AM Nature Wood Group Limited Provides Update on First-Half 2023 Financial Performance (PR Newswire) -7.57%
Oct-16-23 03:16PM Nature Wood Group Limited Announces Partial Exercise of the Underwriter's Over-Allotment Option (GlobeNewswire)
Sep-25-23 08:30AM Nature Wood Group Limited Announces Strategic Cooperation with the Research Institute of Wood Industry, Chinese Academy of Forestry, Launching Its Biomass Supramolecular New Materials Innovation Project (GlobeNewswire)
Sep-14-23 11:29AM Nature Wood Group Limited Announces Closing of $6.75 Million Initial Public Offering (GlobeNewswire) +6.15%
Sep-12-23 12:44AM Nature Wood Group Limited Announces Pricing of $6.75 Million Initial Public Offering (GlobeNewswire)
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap1.88MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-99.99%
Dividend-Sales Q/Q-
Insider Own32.61%Inst Own2.69%
Insider Trans0.00%Inst Trans-
Short Float2.40%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume81.71K52W Range2.31 - 89.50
Apr-23-24 05:15PM AERWINS Technologies Announces Additional Staff Determination (GlobeNewswire) -5.13%
Mar-28-24 11:25AM AERWINS Technologies Announces 1-For-100 Reverse Stock Split (GlobeNewswire) -12.90%
Dec-04-23 07:21AM 10 Best Debt Free Penny Stocks To Buy Now (Insider Monkey)
Oct-24-23 08:41AM Why Is Aerwins Technologies (AWIN) Stock Up 26% Today? (InvestorPlace) +8.51%
07:45AM Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Oct-09-23 08:30AM AERWINS Plans to Obtain XTURISMO FAA Approval Established US Subsidiary (Newsfile) +13.23%
Oct-03-23 08:03AM Why Is Aerwins Technologies (AWIN) Stock Down 18% Today? (InvestorPlace) -16.77%
Oct-02-23 07:44AM Why Is Aerwins Technologies (AWIN) Stock Up 112% Today? (InvestorPlace) +89.57%
Aug-07-23 08:11AM 15 Worst Performing Tech Stocks in 2023 (Insider Monkey) -11.66%
Jul-17-23 10:15AM Aerwins Patented Air Mobility Platform to Revolutionize Low Altitude Flights for Vehicles Opening Flight Possibilities for Electric Vehicles (Newsfile) -21.33%
NUZE - Nuzee Inc - Stock Price Chart
TickerNUZE [NASD]
CompanyNuzee Inc
CountryUSA
IndustryPackaged Foods
Market Cap2.09MEPS (ttm)-11.98
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-3.14%
P/S0.62EPS next 5Y-
P/B0.73EPS Q/Q32.33%
Dividend-Sales Q/Q30.27%
Insider Own17.76%Inst Own11.85%
Insider Trans0.00%Inst Trans-
Short Float0.53%EarningsJan 17/b
Analyst Recom1.00Target Price8.00
Avg Volume13.49K52W Range1.13 - 13.00
Apr-11-24 05:30PM NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b) (PR Newswire)
Feb-29-24 04:15PM NuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (PR Newswire) -7.06%
Feb-14-24 04:30PM NuZee, Inc. Announces Extension for Filing of Form 10-Q (PR Newswire) +11.76%
Jan-26-24 04:15PM NuZee, Inc. Announces Receipt of NASDAQ Notification (PR Newswire)
Jan-17-24 08:30AM NuZee, Inc. Reports Full-Year Fiscal 2023 Financial Results (PR Newswire) -7.90%
Dec-29-23 04:30PM NuZee, Inc. Announces Delay in Filing Form 10-K (PR Newswire) -6.96%
Dec-12-23 04:30PM NuZee, Inc. Appoints Randell Weaver as President and Chief Operating Officer (PR Newswire) -6.97%
Dec-05-23 12:32PM NuZee, Inc. Announces Full Exercise and Closing of Over-Allotment Option in Connection with its Underwritten Public Offering (PR Newswire) -14.41%
Nov-07-23 09:30AM Stone Brewing Launches Full Line of Specialty Coffee (PR Newswire)
Oct-20-23 04:01PM NuZee Announces Closing of $1.275 Million Underwritten Public Offering of Common Stock (PR Newswire)
NIVF - NewGenIvf Group Ltd - Stock Price Chart
TickerNIVF [NASD]
CompanyNewGenIvf Group Ltd
CountryTaiwan
IndustryHealth Information Services
Market Cap6.64MEPS (ttm)-0.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.43EPS Q/Q-569.60%
Dividend-Sales Q/Q-
Insider Own0.93%Inst Own49.11%
Insider Trans0.00%Inst Trans2.16%
Short Float0.40%Earnings-
Analyst Recom-Target Price-
Avg Volume5.26M52W Range0.63 - 17.24
Apr-22-24 09:00AM NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings (GlobeNewswire) +66.23%
IBRX - ImmunityBio Inc - Stock Price Chart
TickerIBRX [NASD, RUT]
CompanyImmunityBio Inc
CountryUSA
IndustryBiotechnology
Market Cap4.95BEPS (ttm)-1.13
P/E-EPS this Y31.75%
Forward P/E-EPS next Y13.19%
PEG-EPS past 5Y1.17%
P/S7989.57EPS next 5Y-1.70%
P/B-EPS Q/Q-29.72%
Dividend-Sales Q/Q90.41%
Insider Own79.68%Inst Own8.46%
Insider Trans0.00%Inst Trans10.14%
Short Float40.05%Earnings-
Analyst Recom2.00Target Price5.00
Avg Volume4.81M52W Range1.25 - 6.93
Apr-25-24 12:03AM ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer (Business Wire) +6.02%
Apr-23-24 04:55PM ImmunityBio's bladder cancer therapy wins FDA approval (Yahoo Finance Video) +11.13%
Apr-22-24 09:56PM ImmunityBio Announces FDA Approval of ANKTIVA, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (Business Wire) -6.26%
Apr-19-24 11:02AM 12 Most Shorted Stocks in 2024 (Insider Monkey) +7.33%
Mar-19-24 09:53PM IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Mar-14-24 08:45AM Biotech's Role in Addressing the Pancreatic Cancer Emergency (PR Newswire)
Mar-06-24 09:00AM NIAID-Sponsored Study Shows N-803 Combined with Neutralizing Antibodies Could Lead to Sustained HIV Viral Control After Discontinuation of Antiretroviral Therapy (Business Wire) +5.39%
Mar-05-24 09:00AM N-803 Combined with Natural Killer Cells Showed Potential to Reduce HIV Viral Load in HIV Positive Subjects; Part of HIV Cure Study (Business Wire)
Feb-21-24 09:00AM ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial (Business Wire)
Feb-05-24 09:00AM ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG (Business Wire)
SFWL - Shengfeng Development Ltd. - Stock Price Chart
TickerSFWL [NASD]
CompanyShengfeng Development Ltd.
CountryChina
IndustryIntegrated Freight & Logistics
Market Cap139.44MEPS (ttm)0.12
P/E13.45EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y52.60%
P/S0.35EPS next 5Y-
P/B1.28EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own90.79%Inst Own0.52%
Insider Trans0.00%Inst Trans-
Short Float6.91%Earnings-
Analyst Recom-Target Price-
Avg Volume276.23K52W Range1.38 - 17.60
Jun-12-23 08:00AM Shengfeng Development Limited Purchases Electric Heavy-Duty Trucks (PR Newswire)
Apr-04-23 02:43PM Univest Securities, LLC Announces Closing of $9.6 Million Initial Public Offering of Class A Ordinary Shares for its Client Shengfeng Development Limited (NASDAQ: SFWL) (GlobeNewswire)
02:25PM Shengfeng Development Limited Announces Closing of Initial Public Offering (PR Newswire)
Mar-31-23 09:30AM Shengfeng Development Limited Announces Pricing of Initial Public Offering (PR Newswire)
ATXI - Avenue Therapeutics Inc - Stock Price Chart
TickerATXI [NASD]
CompanyAvenue Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap274.41MEPS (ttm)4.87
P/E1.27EPS this Y58.16%
Forward P/E-EPS next Y9.76%
PEG-EPS past 5Y50.07%
P/S-EPS next 5Y-
P/B1.34EPS Q/Q358.44%
Dividend-Sales Q/Q-
Insider Own11.82%Inst Own2.79%
Insider Trans-10.55%Inst Trans4.58%
Short Float0.01%EarningsMar 18/a
Analyst Recom1.00Target Price56.25
Avg Volume24.43K52W Range6.39 - 93.75
Apr-24-24 07:30AM Avenue Therapeutics Announces Reverse Stock Split (GlobeNewswire) -29.63%
Mar-25-24 08:30AM Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 (GlobeNewswire)
Mar-19-24 06:53AM ATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Mar-18-24 04:05PM Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-15-24 08:15AM Avenue Therapeutics Receives Positive Listing Determination from Nasdaq (GlobeNewswire)
Mar-11-24 08:00AM Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting (GlobeNewswire) -15.62%
Feb-22-24 08:30AM Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy (GlobeNewswire)
Jan-16-24 08:40AM Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE) -11.03%
Jan-11-24 08:00AM Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference (GlobeNewswire)
Jan-05-24 09:15AM Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds (GlobeNewswire) -44.64%
XBP - XBP Europe Holdings Inc - Stock Price Chart
TickerXBP [NASD]
CompanyXBP Europe Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap45.26MEPS (ttm)-2.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-7853.04%
Dividend-Sales Q/Q-
Insider Own72.32%Inst Own22.24%
Insider Trans-0.46%Inst Trans-68.24%
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume24.82K52W Range1.14 - 47.40
Apr-01-24 05:00PM XBP Europe Holdings, Inc. Reports Full Year 2023 Results (GlobeNewswire)
Jan-23-24 08:30AM Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI (GlobeNewswire) -7.14%
Jan-03-24 11:25AM XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024 (GlobeNewswire)
MOBX - Mobix Labs Inc - Stock Price Chart
TickerMOBX [NASD]
CompanyMobix Labs Inc
CountryUSA
IndustrySemiconductors
Market Cap90.33MEPS (ttm)-0.66
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B20.68EPS Q/Q108.76%
Dividend-Sales Q/Q-
Insider Own38.82%Inst Own0.96%
Insider Trans2.03%Inst Trans-43.92%
Short Float0.32%Earnings-
Analyst Recom-Target Price-
Avg Volume102.53K52W Range1.17 - 12.50
Apr-23-24 08:00AM Mobix Labs, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference Call (Business Wire) +16.08%
Apr-11-24 08:00AM Mobix Labs Announces MMS Technical Sales as Manufacturers Rep (Business Wire)
Mar-28-24 08:00AM Mobix Labs Broadens Product Portfolio to Include Medical Technology Sector (Business Wire)
Mar-21-24 08:00AM Mobix Labs Secures Orders for Connectors into 2026 for Gulfstream Jets (Business Wire)
Mar-19-24 08:00AM Mobix Labs Secures $100 Million Committed Equity Facility (Business Wire) +9.95%
Mar-11-24 09:00AM Mobix Labs Announces Mid-Quarter Business Update (Business Wire)
Mar-07-24 04:05PM Mobix Labs to Attend 36th Annual Roth Conference (Business Wire) -6.45%
Mar-04-24 08:00AM Mobix Labs Establishes Technical Advisory Board (Business Wire)
Feb-29-24 01:30PM Mobix Labs Announces Business Update (Business Wire)
Feb-13-24 09:00AM Mobix Labs Awarded Key Design Win By RaGE Systems to Develop Next Generation 5G Antenna for Radar and Imaging Sensors (Business Wire)
BDRX - Biodexa Pharmaceuticals Plc ADR - Stock Price Chart
TickerBDRX [NASD]
CompanyBiodexa Pharmaceuticals Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap0.31MEPS (ttm)-19.22
P/E-EPS this Y91.79%
Forward P/E-EPS next Y15.41%
PEG-EPS past 5Y86.34%
P/S0.66EPS next 5Y-
P/B3.41EPS Q/Q99.66%
Dividend-Sales Q/Q-61.66%
Insider Own-Inst Own42.90%
Insider Trans-Inst Trans-10.57%
Short Float-EarningsApr 19/b
Analyst Recom1.00Target Price8.00
Avg Volume2.10M52W Range0.67 - 21.44
Apr-26-24 03:18PM Why Is Biodexa (BDRX) Up 70% Today? (InvestorPlace) +79.36%
08:30AM Biodexa Enters Into Exclusive License to eRapa , a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP) (GlobeNewswire)
Apr-19-24 08:00AM Preliminary Results for the Year Ended 31 December 2023 (GlobeNewswire) -8.30%
Mar-28-24 11:22AM Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today? (InvestorPlace) +88.59%
08:15AM Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers (ACCESSWIRE)
Mar-01-24 08:00AM Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone (ACCESSWIRE) +7.09%
Feb-23-24 08:30AM Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update (GlobeNewswire)
Feb-08-24 08:30AM Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients (GlobeNewswire)
Feb-07-24 08:30AM Biodexa Announces Allowance of U.S. Patent Covering Tolimidone (GlobeNewswire) -11.77%
Jan-22-24 08:30AM Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 (GlobeNewswire)
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.